Vivani Medical, Inc. (VANI)
Fuera de horario:
Vivani Medical, Inc.
1350 South Loop Road
Alameda, CA 94502
United States
415 506 8462
https://www.vivani.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 36
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Adam Mendelsohn Ph.D. | Co-Founder, CEO & Director | 609.62k | N/D | 1982 |
| Mr. Truc Le M.B.A. | Chief Operations Officer | 486.3k | N/D | 1953 |
| Dr. Lisa E. Porter M.D. | Chief Medical Officer | 482.13k | N/D | 1964 |
| Ms. Brigid Ann Makes | Chief Financial Officer | 204.63k | N/D | 1956 |
| Mr. Donald Dwyer M.B.A. | Chief Business Officer & Corporate Secretary | 190.97k | N/D | 1959 |
Descripción
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Vivani Medical, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
